More About the Webinar
The Early Identification and Diagnosis of Axial Spondyloarthritis (EIDA) Project is designed to raise awareness and provide education on the clinical features that may indicate axSpA. Our objective is to enhance understanding among non-rheumatology healthcare professionals who treat patients with chronic back pain, promoting timely referrals and reducing the gap between symptom onset and diagnosis.
By attending this webinar, you will play a crucial role in improving long-term outcomes for axSpA patients. With your help, we can provide them with the benefits of early and effective therapy, ultimately enhancing their quality of life.
Don’t miss this opportunity to make a significant impact on the lives of those suffering from axSpA. Register today and be a part of the solution!
Learning Objectives:
- Develop an awareness of axSpA as treatable cause of back pain
- Recognize an inflammatory back pain pattern as a typical presentation of axSpA
- Identify other common clinical features of axSpA that occur outside the spine
- Gain knowledge of basic principles of diagnosis and treatment of axSpA as applied by rheumatologists
- Understand appropriate testing for a patient with chronic back pain suspected of axSpA and apply criteria for referral to rheumatology
About Your Speaker:
Philip J. Mease, M.D., serves as a Clinical Professor at the University of Washington School of Medicine and as Director of Rheumatology Research at Swedish Medical Center in Seattle. Based at Seattle Rheumatology Associates, Dr. Mease obtained his degrees from Stanford University Medical School and completed his residency at the University of Washington.
With a focus on clinical trials for rheumatic diseases and research in disease state metrics, he is a co-chair of three OMERACT working groups and a member of the Soluble Biomarker group.
A founding organizer and Past-President of GRAPPA, he is also a member of SPARTAN and TREG, with 18 book chapters and nearly 400 journal articles to his credit.